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Transplant recipients develop multiple cutaneous lesions. 
We have identified human papillomavirus (HPV) DNA in 
these lesions using three different techniques, namely 
polymerase chain reaction (peR), in situ hybridization, and 
Southern blotting. By peR, HPV DNA was detected in 43 of 
62 samples: warts, actinic keratoses, Bowen's disease, and 
squamous cell carcinomas. Surprisingly, HPV 6/11, usually 
associated with mucosa, were frequently found in benign, 
premalignant, and malignant cutaneous lesions (30/43 
cases). Some of these biopsies were simultaneously tested by 
in situ hybridization and/or Southern blotting. By in situ 
hybridization, HPV 6/11 were identified in two warts and 
I mmunosuppressed patients such as transplant recipients de-velop numerous cutaneous lesions, profuse verrucosis, and carcinomas on sun-exposed areas [1,2). In these benign and malignant lesions HPV DNA has been detected [3-6). Sev-eral HPV types have been detected in such biopsies: HPV 1, 
2, 3, 4, and 10 were frequent in skin warts [3,7), as in the general 
population; benign HPV 2 and 4 were also found in squamous cell 
carcinomas [4). oncogenic HPV 16 was seen in benign skin warts [7) 
and in periungual squamous cell carcinomas [8,9). HPV 6/11, 
which usually infect benign genital lesions such as condylomas or 
benign laryngeal papillomas of the general population [10,11), have 
also been detected in perianal squamous cell carcinomas from trans-
plant recipients [12). This investigation reports the detection of 
mucosal HPV types 6/11 in different cutaneous lesions from trans-
plant recipients using peR and, in some specimens, in situ hybrid-
ization and Southern blotting. 
MATERIALS AND METHODS 
Biopsy Specimens Sixty-two cutaneous biopsies were excised from 22 
renal and five cardiac transplant recipients with multiple lesions on sun-ex-
posed areas (face, arm, hand, leg, top of back, and chest). Ten skin biopsies 
were taken from normal individuals with similar lesions, and six genital 
warts and five juvenile laryngeal papillomas were also tested. 
Each biopsy was cut into two parts: one was snap frozen and stored at 
- 20" C and the other was fixed in Bouin's or Baker's solution and embedded 
in paraffin. Four-micrometer frozen sections were layered on aminopropyl-
triethoxysilane (Aldrich Chemic, Strasbourg, France)-treated slides and 
fixed in acetone for itl sitJl hybridization. One slide from each paraffin-em-
bedded lesion was routinely stained with hematoxylin-eosin for histologic 
examination. 
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one squamous cell carcinoma among 29 tissue specimens 
tested. Of the three samples examined by Southern blotting, 
HPV 6/11 were detected in one squamous cell carcinoma. In 
patients from a control population cutaneous biopsies did not 
exhibit HPV types 6/11 except in Bowen's disease; HPV 
types 1 or 2 were mainly found in benign warts. These find-
ings suggest that in transplant recipients, HPV can lose their 
specificity towards mucosa or cutaneous epithelium. The 
significance of the presence of HPV 6/11 in skin lesions 
remains unknown. Key words: HPV 6/11/skin lesions/renal 
transplant recipients/cardiac transplant recipients. ] Invest 
DermatoI101:286-291, 1993 
Polymerase Chain Reaction Studies Total cellular DNA was extracted 
from biopsies by phenol-chloroform-isoamyl alcohol and precipitated with 
ethanol. PCR was performed on cellular DNAs using a Perkin-Elmer Cetus 
DNA thermal cycler according to the procedure and precautions previously 
described [13], with primers chosen in E6 - E7 region ofHPV types 5, 6/11 , 
16, and 18 (Table I). The amplification protocol was annealing for 1 min at 
55"C, extension for 1 min at 72"C, and denaturation for 1 min at 95"C, 
except for HPV 5, for which the annealing temperature was 58"C. Ampli-
fied products were detected on ethidium bromide-stained gels and Southern 
blots were hybridized with radiolabeled specific oligonucleotides (Table I) . 
To prevent artefactual results, cellular and plasmid DNAs were prepared 
in different rooms. Furthermore, some cellular DNAs used in these experi-
ments were extracted in different years. Buffer and primers were submitted 
to UV for 3 hand aliquoted. Positive and negative controls were included in 
the reactions. 
In Sit" Hybridization HPV la, 2a, 5, 6a, II, 16, and 18 (provided by G. 
Orth, Paris and H . zur Hausen, Heidelberg) cloned in pBR322 plasmid were 
prepared and purified on cesium chloride gradients. Plasmid DNAs were 
biotinylated by nick translation using biotinylated ll-dUTP (Sigma, Saint 
Louis, MO). The sections were processed under stringent conditions at 
Tm-17"C and DNA-DNA hybrids were detected with a three-step proce-
dure using streptavidin-alkaline phosphatase complex [14). 
Southern Blot Ten micrograms of total cellular DNA from eight biopsy-
specimens (three from transplant recipients and five from controls) were 
digested with Pst I (Boehringer, Mannheim, Germany) in buffer from the 
supplier and electrophoresed on a 1 % agarose gel. The fragments were then 
transferred onto a Gene Screen Plus membrane (NEN , Boston, MA). Plas-
mid HPV types la, 2a, 5, 6a, 11a, 16, and 18 probes were labeled by nick 
translation using 32P_dCTP (specific activity: 800 Cijmmol; Amersham). 
Membranes were prehybridized in 10 ml of 50% deionized formamide, 1 % 
sodium dodecyl sulfate (SDS), 1 M NaCI, 10% dextran sulfate, for 6 h at 
42"C. One milliliter of solution containing about 5 X 106 cpm of labeled 
probe (specific activity: 8 X 107 cpm/J1g DNA) and 100 J1g of salmon sperm 
DNA were added after denaturation by heating in boiling water for 10 min 
and chilling on ice. Hybridization was carried out overnight at 42"C. The 
membranes were carefully washed successively in 2 X sodium saline citrate 
(1 X SSC: 0.15 M NaCI, 0.015 M sodium citrate), 2 X SSC plus 1% SDS, 
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Table I. Primers and Oligoprobes for HPV 5, 6,11,16, and 18 Chosen in E6-E7 Region 
HPV Localization Sequences Size of Fragments Tm 
Primers 
HPV5 609 - 630 5' TTCATAAGGTGAGGAACGCCTG 3' 
797 - 897 3' CGAAAGGTTGTCGATGACTGGC 5' 288 bp 
HPV6/11 514 - 533 5' TACACTGCTGGACAACATGC 3' 
797 - 815 3' CACACAGGGTAGACGCGTG 5' 301 bp 
HPV 16 548 - 571 5' CCCAGCTGTAATCATGCATGGAGA 3' 
778 - 801 3'ACCTTCTGGACAATTACCCGTGTG5' 253 bp 
PVH 18 540 - 560 5' CGACAGGAACGACTCCAACGA 3' 
718-741 3' TCAATTAGTAGTTGTAAATGGTCG 5' 201 bp 
Probes 
HPV 5 797-818 5'CAACGAAAGGATCTCTTACAAA3' 50SC 
69 °C 
62.3°C 
59.2°C 
HPV 6/1 t 584-602 5'GACCTGTTGCTGTGGATGT3' 
HPV16 700 - 717 5' CCGGACAGAGCCCATTAC 3' 
HPV18 601-620 5' TAAGGCAACATTGCAAGACA 3' 
and 0.1 X SSC solutions. They were further exposed to X-OMA T (Kodak) 
films for 1-14 d using cassettes with intensifying screens. Membranes were 
successively hybridized with the different HPV probes after dehybridization 
according to the manufacturer's instructions and control for the loss of 
radioactivi ty . 
RESULTS 
All biopsy specimens we:e examine~ after stai~ing. with ~ema.tox.y­
lin-eosin and were classified according to their histologic cntena. 
Data comparing histologic diagnosis and results of experimental 
studies are shown in Table II . 
Transplant Recipient Lesions PCR amplification of HPV 
types 5, 6/11, 16, and 18 was performed on skin lesions. Of the 62 
samples, 43 (69%) were HPV DNA positive; 30 of 43 (69%) exhib-
ited HPV 6/11 DNA, four of 11 (36%) benign vulgaris warts, seven 
of seven premalignant actinic keratoses, four of four premalignant 
Bowen's disease, and 15 of 21 (74%) squamous cell carcinomas 
(Table II). 
Among 30 biopsies containing HPV 6/11 DNA by PCR (Table 
III), 12 samples (three warts, four actinic keratoses, three Bowen's 
disease, two squamous cell carcinomas) contained these HPV types; 
the other probes gave negative reactions. HPV 5 and HPV 6/11 
were found in seven cases (one actinic keratosis, six squamous cell 
carcinomas). The other 11 samples contained HPV 6/11 and HPV 
16, 18, and/or 5 (one wart, two actinic keratoses, one Bowen's 
disease, seven squamous cell carcinomas). 
After HPV 6/11 amplification and hybridization of Southern 
blots with radioactive probes, bands of various intensities were seen, 
indicating that various amounts ofHPV 6/11 DNA were present in 
these samples. Figure 1 shows an example of results obtained after 
amplification of squamous cell carcinoma DNAs. In samples con-
~ainin~ more than one. type of DNA, HPV 6/11 were predominant 
In bemgn and premalignant lesions, but in squamous cell carcino-
mas they were present in smaller amounts than in oncogenic types. 
J:IPV 6(11 DNA :vas identified (Table III) not only in seven 
patients wI~h sl11gl~ biopsies but also in seven other patients having 
s~veral excls.ed leslOns. In this latter case, samples were taken at 
~dferent. penods, therefore excluding the possibility of contamina-
tIOn dunng DNA extraction. Furthermore, amplification without 
DNA or amplification of either MRC5 cell DNA or dermal DNA 
extracted from normal skin gave negative results in every case. Be-
cause HPV: 6/1.1 were usually found in benign mucosal lesions, 
PCR amplifications and analyses of amplification products were 
repeated at least two or three times . Similar results were detected 
consistently. 
Twenty-nine of the 62 biopsies (Table IV) were a.lso screened for 
the presence of HPV DNA by in situ hybridization with HPV type 
1,2,5,6/11,16, and 18 probes; 12 of29 contained HPV DNA. The 
positive signal was always nuclear and was located in intermediate 
and upp~r epithelial cell layers. Furthermore, it was usually in foci 
of a few 111fected cells. HPV 6/11 were identified in three samples: 
two warts and one squamous cell carcinoma (Fig 2); these results 
were confirmed with PCR. In warts, HPV 6/11 were associated 
with HPV 1 and/or 2 a.nd 1~; in the squamous cell carcinoma, on.ly 
HPV types 6/1 .1 v.:ere Ide~tl.fied: Three.to five sections per sample 
were tested by III SItu hybndlzatlon, which gave similar reactions. 
Tissue sections were negative when the DNA probe was omitted 
or replace.d by the. p~R322 probe. HPV 16 and 18 probes were 
assayed With CaSb, SlHa, and HeLa cells containing, respectively, 
600 copies ofHPV 16, one to two copies ofHPV 16, and 10-50 
copies of HPV 18. CaSki and SiHa cells were positive only with 
HPV 16 p~obe, HeLa cells o~ly with HPV 18 probe. 
Companng the results obtallled by PCR and in situ hybridization 
Table II. Frequency of HPV 6/11 Detected by PCR in Skin Lesions from Transplant Recipients and Normal Population' 
Lesions 
Warts 
Keratoacanthomas 
Actinic keratoses 
Bowen's disease 
Squamous cell carcinomas 
Total 
Controls 
Genital condylomas 
Latyngeal papillomas 
Total 
18 
2 
12 
6 
24 
62 
• PCR amplification of HPV types 5, 6/11, 16, and 18. 
• HPV DNA +, number of lesions containing HPV DNA. 
Transplant Recipients 
HPVb 
DNA+ 
11 
0 
7 
4 
21 
43 
, HPV 6/11 +, number of lesions containing HPV types 6/11 DNA. 
HPV' 
6/11 + 
4 (36%) 
0 
7 (100%) 
4 (36%) 
15(71%) 
30 (69%) 
Non-Transplant Recipients 
HPVb HPV' 
Total DNA+ 6/11 + 
3 0 0 
3 2 2 
4 2 0 
10 4 2 
6 6 6 
5 5 5 
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Table III. Detection of HPV 6/11 by peR" in 30 Skin Lesions from Transplant Recipients 
Patients Lesions 
Renal transplant recipients 
A Warts 
B Warts; 
actinic keratosis 
Squamous cell carcinomas 
C Warts 
D Warts 
E Actinic keratosis; 
squamous cell carcinoma 
F Actinic keratosis; 
Bowen's disease 
G Actinic keratosis; 
Bowen's disease 
H Actinic keratosis 
I Squamous cell carcinoma 
J Squamous cell carcinoma 
K Squamous cell carcinoma 
Cardiac transplant recipients 
L Actinic keratosis 
M Bowen's disease 
N Squamous cell carcinomas 
'peR amplification of HPV types 5, 6/11, 16, and 18 . 
• +, Positive HPV type DNA. 
Number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
' +/-, Weak positivity; the othet HPV types tested were negative. 
with HPV type 5, 6/11,16, and 18 probes, an HPV DNA was more 
frequently detected by PCR than by in situ hybridization, 25 of 29 
(86%) and eight of 29 (27%), respectively. HPV 6/11 were also 
more common with PCR than with in situ hybridization (Table IV), 
20 of25 (80%) and 3 of8 (37%), respectively. By peR, HPV 6/11 
were identified in HPV-positive samples (three of six warts, six of 
six actinic keratoses, four of five Bowen's disease, and seven of nine 
squamous cell carcinomas), whereas by in situ hybridization they 
HPV Types 
Localization 5 6/11 16 18 
Arm +h 
Finger + 
Neck + 
Finger + + 
Back + + + 
Hand + 
Back + 
Back + + 
Back + + 
Back + + 
Neck + + 
Cheek + + 
Forehead + 
Nose + 
Back + + 
Temple + + 
Nose + 
Leg + 
Ear + 
Leg + 
Lip + + + 
Neck + + +/-' +/-
Hand + + 
Hand + + + 
Arm + + 
Face + 
Neck + + 
Sternum + + 
Temple + + 
Ear + + + 
were detectable only in two of three warts and one of four squamous 
cell carcinomas, the other samples being negative. 
To avoid false-positive reactions of peR, the results were exam-
ined according to the patients, the location of the lesions, and the 
time of excision. HPV 6/11 were found in cutaneous lesions from 
14 of 22 (64%) patients with a renal transplant and three of five 
(60%) patients with a cardiac transplant. These biopsies were taken 
from various body sites. Furthermore, when several specimens of 
_1037bp 1 2 3 4 5 6 7 8 9 M 
_475 
301bp_ 315 
301bp_ 
141 
B 
Figure 1. PCR amplification of squamous cell carcinoma DNAs from renal transplant recipients with HPV 6/11 primers. Equal amounts of amplified 
products were loaded and separated electrophoretically. A) No detection of amplified product on ethidium bromide-stained gel. B) Detection of amplified 
product on Southern blotting hybridized with 32P-labeled specilic oligonucleotide probe. Lallf 1, control amplification without DNA. Lalle5 2-9, amplified 
products of squamous cell carcinoma DNAs; positive reactions are seen in falles 5 - 7 (patient B) and (patient I) . Latle M, Molecular weight markers, pBR 322 
digested with Taq I restriction enzyme. 
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Table IV. Detection of HPV Types in Skin Lesions from Transplant Recipient by III Sitll Hybridization and PCR 
HPV Types Total HPV DNA+' HPV 6/11+b 
Lesions Number ISH' PCRJ ISH' ISH' PCRJ ISH' PCRJ 
1 1,6/11,16 6/11 3/6 3/6 5/6 2/6 2/6 
2 1,2,5,16 5 
Warts 
3 2,6/11 6/11 
4 -I 16 
5 6/11 
6 
7 1,2 6/11 
8 2 6/11 2/7 0/7 6/7 0/6 6/7 
9 6/11 
, Actinic keratoses 
10 
11 5,6/11 
12 6/11 
13 6/11 
14 1,2 6/11 3/6 2.6 5/6 0/6 4/6 Bowen's disease 
15 1,2,16,18 
16 16 6/11, 16 
17 6/11 
18 16,18 
19 6/11 
20 5,6/11 6/11,18 4/10 3/10 9/10 1/6 7/10 
21 1, 16 6/11 
) SeQ 
22 1 18 
23 1,2,18 6/11,16 
24 5,6/11 
25 
26 5,6/11 
27 5 
28 5,6/11,16,18 
29 5,6/11 
• HPV DNA+, Number of lesions containing HPV DNA. 
; HPV 6/11+, Number of lesions containing HPV types 6/11 DNA. . 
, ISH, i" sitll hybridization with detection of benign HPV types 1, 2, 6/11 ond potentially oncogeOlc HPV types 5, 16, 18. 
i PCR amplification of HPV types 5, 6/11, 16, and 18. . 
'ISH, in sill< hybridization with detection of benign HPV types 6/11 and potentially oncogelllc HPV types 5,16,18. 
1- no HPV DNA was detected. 
I 
... 
I sec, squamous cell carcinoma. 
one patient (patient B, Table III) were studied, they were ~xcised 
over a period of 3 years, and the DNA was extracted at different 
periods.. . 
Three biopsy speCimens (one wart, two squamous cell carC1l10-
mas) have been tested with PCR, ill situ hybridization, and Southern 
blotting (Table V). By Southern blotting, only one squamous cell 
) carcinoma (from patient 1, Table III, corresponding to case 5, Table 
V) was found to contain HPV types 6/11 (Fig 3), as was also shown 
by PCR. The wart sample was HPV 6/11 positive and was negative 
with other HPV types tested by PCR; the two squamous cell carci-
nomas contained not only HPV 6/11 DNA but also HPV 5 and/or 
16 DNA. By ill situ hybridization, HPV 6/11 was detected in only 
one squamous cell carcinoma and was associated with HPV 16/18; 
HPV types 1 and 2 were found in one sample. 
Non - Transplant-Recipient Lesions A few similar lesions 
from controls were obtained and compared to those of transplant 
recipients for their content in HPV DNA type 6/11. Of the ten skin 
specimens tested by PCR (Table II), four (40%) contained HPV 
DNA; HPV 6/11 were identified only in two cases of Bowen's 
, disease, and these lesions also contained HPV16 or 16 and 18 DNA. 
The eight other samples were negative with each probe tested. 
Four samples (three warts and one squamous cell carcinoma) were 
tested by PCR, in situ hybridization, and Southern blotting for HPV 
5, 6/11, 16, and 18 (Table V). They were also tested by in situ 
hybridization and Southern blotting with plasmid probes types 1 
and 2. By PCR, all the specimens were negative. HPV type 1 and/or 
2 DNA was found in warts by both in situ hybridization and South-
ern blotting. 
In controls tested by PCR, i,·, situ hybridization, or Southern 
blotting, each geni~al condyloma and juvenile laryngeal papilloma 
was found to conta1l1 HPV 6/11 DNA; they were negative for the 
other HPV types tested (Table II). 
DISCUSSION 
In this investigation we have shown that HPV types 6/11 can be 
detected with PCR,.in sitlt hyb~idization, or Southern blotting in 
some cutaneous bel1lgn, premalIgnant, or malignant lesions from 
organ trans'pla~t recipients. The lesions appeared several years after 
graftmg. BIOpSies were taken at different body sites on sun-exposed 
areas. HPV type 6/11 DNAs were rarely detected in similar skin 
lesions from normal population. 
The identification of these HPV types in cutaneous samples was 
unexpected ~ecause they ~e known to infect mucosa and are usually 
associated With bel1lgn leSIOns. On the contrary, potentially onco-
genic HPV types,. mainly found in mucosa, have already been found 
111 cutaneous leSions; HPV 16, usually associated with cervical 
cancers [15], w.as detected in cutaneous Bowen's disease and squa-
mous cell carcmomas from Immunocompetent patients [8,9,16-
20,21] and ~rom re~lal transplant recipients [13]. HPV 16 has also 
be~n f~und 111 a bel1lgn wart from an immunosuppressed patient [7]. 
It IS difficult to compare the frequency of HPV 16 in cutaneous 
sam~les. reported by various investigators, as techniques of different 
sensltlvlty have been used, in situ hybridization, Southern blotting, 
and PCR. 
The presence of HPV 6/11 in skin lesions has rarely been re-
ported. HPV 11 DNA was mentioned in one case of verrucous 
carcinoma of the leg from a non-immunocompromised patient [22], 
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Figure 2. In situ hybridization with biotinylated HPV 6/11 probes under 
stringent conditions in a paraffin-embedded squamous cell carcinoma from a 
renal transplant recipient. a) Alkaline phosphatase staining pattern of nuclei 
containing HPV 6/11 DNA in epithelial cells from upper layers. b) Detail of 
positive nuclei at higher magnification. D, Dermis; E, Epidermis. Bar, 
100/.lm in (a) and 25 /lm in (b). 
and an HPV 6 was also found and associated with HPV 18 in one 
case of verrucous papules scattered over the arms and legs of a 
non-immunocompromised patient [23]. Both HPV 6/11 and 16 
were reported in periungual squamous carcinoma in situ [21] . In 
biopsies of our study in which only HPV type 6/11 DNAs were 
detected, it cannot be excluded that other HPV types may be 
present, as only oncogenic types 5, 16, and 18 were tested from 
among 66 distinct HPV types so far identified (10] . In our cases, 
HPV 6/11 as well as potentiaIly oncogenic HPV types 5,16, and 18 
were identified, especially in premalignant and malignant lesions. 
These data suggest that carriage of multiple HPVs is not uncommon 
in transplant recipients, although this has been described only rarely 
[4]. The significance of the presence of mucosa.! HPV 6/11 and their 
association with potentially oncogenic types in skin lesions remains 
unknown. Our findings do not establish a cooperative role or com-
plementation ofHPV 6/11 in lesions coinfected with HPV 5,16, or 
18. However, it cannot be excluded that malignancy could result 
from coinfection of HPV 6/11 with other oncogenic HPY types 
that have not been tested. The physical state of the DNA might play 
an important role in the evolution of these lesions towards malig-
nancy although HPV 11 DNA has been found either integrated in 
cellular DNA in a perianal squamous cell carcinoma from a trans-
plant recipient [12] or as an episomal component in a penile carci-
noma [24J . 
In our study, among lesions from non-immunosuppressed pa-
tients, two cases of Bowen's disease were found to contain HPV 
6/11 DNA; one was located on the nose, the other was on the penis. 
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Table V. Detection of HPV Types in Skin Lesions from 
Transplant Recipients by PCR, 111 Sit", Hybridization, and 
Southern Blot 
HPV Types 
Southem' 
Lesions Number peR" ISH; Blotting 
Warts TFd 1 6/11 2,5 6/11 
NTR' 2 - f 1 1 
NTH 3 1,2 1,2 
NTR 4 2 2 
Squamous cell TR 5 5,6/11 6/11,16,18 6/11 
carcmomas TR 6 5,6/11, 16 1,2,16,18 
NTR 7 
NTR 8 16 
• peR amplification of HPV types 5, 6/ 11, 16, and 18. 
• I" lit" hybridization was done with HPV type 1,2,5, 6/11,16, and 18 probes. 
' Southern blotting was done with HPV rype 1,2,5, 6/11,16, and 18 probes 
j TR, transplant recipients. 
, NTR, non-transplant recipients. 
J -, no Hl'V DNA was detected with the HPV probes tested. 
These two locations may explain the presence of such HPV types, 
which are usually identified at these sites [25,26]. The comparison 
with frequency of HPV 6/11 in the normal population is difficult, 
as these patients have single lesions instead of multiple lesions as in 
transplant recipients. 
The common HPV 6/11 infection in skin epithelium in the 
transplant-recipient population could be explained by immunosup-
pressive treatment, which modifies the microenvironment of epi-
thelial cells, targets of all HPV types. It is also possible that cyto-
kines may function as tumor promoters when the immune system is 
suppressed [12]. 
The association of HPV 6/11 with cutaneous lesions from trans-
plant recipients is clearly documented by our data, as three different 
techniques demonstrate HPV 6/11 DNA in some skin biopsies. 
The specificity and sensitivity of the PCR reaction was proved for 
each primer pair, using dilutions of plasmid-containing HPV DNA, 
as previously reported for HPV 6/11,16, and 18 [13]. To avoid 
misinterpretation of results, positive (plasmid-containing HPV 
DNA) and negative (amplification without DNA or normal human 
DNA) controls were included in each amplification. To exclude 
contamination, DNA extraction and PCR amplification were 
carried out in different laboratories. Furthermore. several lesions 
had been excised from patient B over a period 0(3 years and the 
DNAs were extracted at different times, thus excluding the possi-
bility of contamination during extraction of each sample. III situ 
hybridization specificity has been proved by different controls, i.e., 
lesions unrelated to HPV infections such as molluscum contagio-
sum as well as hybridization of sections without probe or with other 
HPV types such as 1,2,5,16, and 18 [27]. In some cases HPV DNA 
was detected by iI, situ hybridization but not by PCR; this could be 
explained by the high dilution ofHPV DNA in cellular DNA or by 
the absence of infected cells in the part of the lesion for DNA 
extraction. By Southern blotting one squamous cell carcinoma from 
a renal transplant patient showed a typical profile ofHPV 6/11; the 
low frequency oflesions containing HPV DNA could be explained 
by inadequate sampling due to the number of DNA copies diluted in 
cellular DNA. In previous results obtained by Southern blotting, on 
benign lesions from the normal population, it was shown that 48/ 
58 skin warts (sales and hands) contained HPV DNA; they exhib-
ited HPV type 1 in nine cases and type 2 in 34 cases, five containe~ 
both HPV 1 and 2, and none of them displayed HPV types 6/11 
(unpublished results). On the contrary, non-transplant controls of 
condylomas and juvenile laryngeal papillomas (Table II) contained 
HPV 6/11 DNA but none of the other HPV DNA type tested did. 
The presence of mucosal HPV 6/11 in cutaneous lesions from 
transplant recipients probably cannot be explained by contamina· 
tion from genital site, because these patients did not have any geni 
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Figure 3. Example of detection by Southern blotting, under stringent con-
ditions of HPV 6/11 DNA, in a squamous cell carcinoma from a renal 
t anspl;nt recipient (I). Digestion was performed with Pst 1. M, Molecular ~eight markers from A phage digested with Hind III restriction enzyme. 
condylomas, oral papillomas, or larynge~l . papillomas, which are 
usually infected with these HPV types, cltl11cally vIsible. As a small 
;. number of HPV types has been tested on our biopsies, it cannot be 
excluded that another type or a new type could be involved. 
In conclusion, we report the presence of benign mucosal HPV 
6/11 in benign, premal.ignant, and malignant skin lesions. fr~m 
transplant recipients;. tim sugge~ts that HPVs may lose their site 
specificity in such patients. The slgl11ficance of t~e pres.enc~ o.fHPV 
6/11 in cutaneous lesions remains unclear. HPV 111fection 111 Itself IS 
I probably not sufficient for a progressIOn towards maltgnancy; other 
factors such as immunosuppressive treatment, UV, or activated on-
cogenes probably change the epithelial cell environment. 
We tirallk the clitlicialls who collected the biopsies, Dr. C. Hermier for histologic 
classiJicatio" of tire samples, alld Dr. J. Carew for revicwillg tire ElIglisll /Jersioll of 
this manuscript. 
This work was supported by INSERM, Ligue Natiolla le Frallfaise col/tre Ie 
Cancer Camilli Depa rtemet/tal dll RI,cme 1991, MGEN COl/tract 1991, alld Bio-
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